Chiara Ferraris

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Subarachnoid Hemorrhage

Vascular Endothelial Growth Factor

Top Venues

International journal of molecular sciences

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Perrelli, Annalisa Bozza, Chiara Ferraris, Sara Osella, Andrea Moglia, Silvia Mioletti, Luigi Battaglia, Saverio Francesco Retta
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease. Biomedicines 11 (2) (2023)
Andrea Perrelli, Annalisa Bozza, Chiara Ferraris, Sara Osella, Andrea Moglia, Silvia Mioletti, Luigi Battaglia, Saverio Francesco Retta
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease. Biomedicines 11 (2) (2023)
Andrea Perrelli, Annalisa Bozza, Chiara Ferraris, Sara Osella, Andrea Moglia, Silvia Mioletti, Luigi Battaglia, Saverio Francesco Retta
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease. Biomedicines 11 (2) (2023)
Andrea Bianconi, Luca Francesco Salvati, Andrea Perrelli, Chiara Ferraris, Armando Massara, Massimiliano Minardi, Gelsomina Aruta, Miriam Rosso, Barbara Massa Micon, Diego Garbossa, Saverio Francesco Retta
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events. International journal of molecular sciences 23 (23) (2022)
Andrea Bianconi, Luca Francesco Salvati, Andrea Perrelli, Chiara Ferraris, Armando Massara, Massimiliano Minardi, Gelsomina Aruta, Miriam Rosso, Barbara Massa Micon, Diego Garbossa, Saverio Francesco Retta
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events. International journal of molecular sciences 23 (23) (2022)
Andrea Bianconi, Luca Francesco Salvati, Andrea Perrelli, Chiara Ferraris, Armando Massara, Massimiliano Minardi, Gelsomina Aruta, Miriam Rosso, Barbara Massa Micon, Diego Garbossa, Saverio Francesco Retta
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events. International journal of molecular sciences 23 (23) (2022)
Chiara Monge, Ian Stoppa, Chiara Ferraris, Annalisa Bozza, Luigi Battaglia, Luigi Cangemi, Gianluca Miglio, Stefania Pizzimenti, Nausicaa Clemente, Casimiro Luca Gigliotti, Elena Boggio, Umberto Dianzani, Chiara Dianzani
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment. Nanomaterials (Basel, Switzerland) 12 (23) (2022)
Chiara Monge, Ian Stoppa, Chiara Ferraris, Annalisa Bozza, Luigi Battaglia, Luigi Cangemi, Gianluca Miglio, Stefania Pizzimenti, Nausicaa Clemente, Casimiro Luca Gigliotti, Elena Boggio, Umberto Dianzani, Chiara Dianzani
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment. Nanomaterials (Basel, Switzerland) 12 (23) (2022)
Chiara Monge, Ian Stoppa, Chiara Ferraris, Annalisa Bozza, Luigi Battaglia, Luigi Cangemi, Gianluca Miglio, Stefania Pizzimenti, Nausicaa Clemente, Casimiro Luca Gigliotti, Elena Boggio, Umberto Dianzani, Chiara Dianzani
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment. Nanomaterials (Basel, Switzerland) 12 (23) (2022)
Andrea Bianconi, Luca Francesco Salvati, Andrea Perrelli, Chiara Ferraris, Armando Massara, Massimiliano Minardi, Gelsomina Aruta, Miriam Rosso, Barbara Massa Micon, Diego Garbossa, Saverio Francesco Retta
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events. International journal of molecular sciences 23 (23) (2022)
Chiara Ferraris, Clara Rimicci, Sara Garelli, Elena Ugazio, Luigi Battaglia
Nanosystems in Cosmetic Products: A Brief Overview of Functional, Market, Regulatory and Safety Concerns. Pharmaceutics 13 (9) (2021)